Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Brainsway ( (BWAY) ) has provided an announcement.
On June 11, 2025, BrainsWay Ltd. announced positive preliminary results from a multicenter, randomized controlled trial of its accelerated Deep TMS protocol for major depressive disorder (MDD). The study, involving 104 patients across eight sites, demonstrated that the accelerated protocol, which requires fewer clinic visits, achieved comparable efficacy to the standard protocol in reducing depression symptoms. The accelerated treatment was well-tolerated, with no serious adverse events, and showed a quicker median time to remission. This advancement could significantly impact patient accessibility and treatment logistics in mental health care.
The most recent analyst rating on (BWAY) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Brainsway stock, see the BWAY Stock Forecast page.
Spark’s Take on BWAY Stock
According to Spark, TipRanks’ AI Analyst, BWAY is a Outperform.
Brainsway’s strong financial performance, characterized by revenue growth and balance sheet robustness, is the primary driver of the stock’s favorable score. The technical analysis supports a positive momentum, though caution is advised due to high valuation metrics. The positive earnings call further reinforces the company’s potential for growth, albeit with some risks from increased expenses and geopolitical factors.
To see Spark’s full report on BWAY stock, click here.
More about Brainsway
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The company specializes in Deep Transcranial Magnetic Stimulation (Deep TMS) technology, which is FDA-cleared for major depressive disorder, obsessive-compulsive disorder, and smoking addiction. Founded in 2003, BrainsWay operates in the United States and Israel, focusing on increasing global awareness and access to Deep TMS.
Average Trading Volume: 36,030
Technical Sentiment Signal: Buy
Current Market Cap: $220.7M
See more data about BWAY stock on TipRanks’ Stock Analysis page.